UniProt | Protein Name |
---|---|
P21802 |
|
D2CGD1 |
|
S4R381 |
|
A0A141AXF1 |
|
GO Term | Evidence Code | PMID |
---|---|---|
epithelial to mesenchymal transition | ||
limb bud formation | ||
branching involved in prostate gland morphogenesis | ||
multicellular organism development | ||
regulation of smoothened signaling pathway |
GO Term | Evidence Code | PMID |
---|---|---|
collagen-containing extracellular matrix | ||
plasma membrane | ||
extracellular region | ||
cell surface | ||
excitatory synapse |
GO Term | Evidence Code | PMID |
---|---|---|
protein binding | ||
fibroblast growth factor binding | ||
heparin binding | ||
identical protein binding | ||
protein tyrosine kinase activity |
Gene Ontology |
---|
ATP binding |
fibroblast growth factor receptor activity |
nucleotide binding |
transmembrane receptor protein tyrosine kinase activity |
DO ID | Disease Name | Source |
---|---|---|
DOID:0050156 | idiopathic pulmonary fibrosis | |
DOID:0050331 | lacrimoauriculodentodigital syndrome 1 | |
DOID:0050660 | Beare-Stevenson cutis gyrata syndrome | |
DOID:0050861 | colorectal adenocarcinoma | |
DOID:0080001 | bone disease | |
DOID:0081289 | Antley-Bixler syndrome | |
DOID:0081290 | Antley-Bixler syndrome without disordered steroidogenesis | |
DOID:0111337 | Jackson-Weiss syndrome | |
DOID:10283 | prostate cancer | |
DOID:10486 | intestinal atresia |
Species | Gene ID | OrthoDB | Alliance of Genome Resources | Orthologous MAtrix |
---|---|---|---|---|
466220 | 9598_0:002b50 | PANTR01695 | ||
715949 | MACMU46194 | |||
100009417 | RABIT07079 | |||
100025727 | MONDO02449 | |||
100033956 | HORSE15891 | |||
100049483 | ORYLA05261 | |||
100084641 | ORNAN07383 | |||
100124910 | Xenbase:XB-GENE-1018296 | |||
100171540 | 9601_0:002a96 | PONAB01766 | ||
100223379 | TAEGU26613 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.1.0
Last updated: December 9, 2024